Title : Egr-1 mediates low-dose arecoline induced human oral mucosa fibroblast proliferation via transactivation of Wnt5a expression.

Pub. Date : 2020 Nov 10

PMID : 33167868






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Egr-1 mediates low-dose arecoline induced human oral mucosa fibroblast proliferation via transactivation of Wnt5a expression. Arecoline early growth response 1 Homo sapiens
2 Treatment with siRNAs specific to Egr-1, Egr inhibitors, or Wnt5a antibody treatment could all inhibit arecoline-induced Wnt5a upregulation and fibroblast proliferation. Arecoline early growth response 1 Homo sapiens
3 CONCLUSIONS: Egr-1 mediates the effect of low dose arecoline treatment on human oral mucosa fibroblast proliferation by transactivating the expression of Wnt5a. Arecoline early growth response 1 Homo sapiens